Clinical trial Recruiting at 3 sites Interventional Ages 9 Months to 17 Months

Telehealth support for infants showing early signs of autism

Official title: Fostering Infant Responsivity and Reciprocity - Support to Thrive. A Multisite Randomized Control Trial of a Preemptive Telehealth Intervention for Infants With Early Signs of Autism Spectrum Disorders

Run by IRCCS Fondazione Stella Maris · NCT06817746 · Data updated 2026-11-12

This study is testing whether telehealth support can help infants under 18 months who show early signs of autism develop better skills and reduce their symptoms.

More Autism Spectrum Disorder (ASD) trials

Quick facts

Study typeInterventional
Ages9 Months to 17 Months
SexAll
Enrollment132 (estimated)
SponsorIRCCS Fondazione Stella Maris
Academic / other
Locations4 sites (Pisa, Italy and 3 other locations)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedAugust 31, 2027
Study endsAugust 31, 2027
Registry record updatedFebruary 10, 2025
Trial IDNCT06817746 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are infants under 18 months who show early signs of ASD and have access to a webcam and internet.

Probably not a fit

Patients with known genetic disorders, significant neurological impairments, or severe sensory/motor disabilities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention focuses on providing pre-emptive support for infants who exhibit early prodromal signs of Autism Spectrum Disorder (ASD). The approach involves telehealth methods, including parent education and the FIRRST program, to enhance developmental skills and potentially mitigate the progression of ASD symptoms. By targeting infants under 18 months with specific risk factors, the study aims to leverage the critical period of brain plasticity for optimal outcomes. The intervention is designed to be accessible through devices with webcams and internet access, facilitating remote participation.

Why it matters

Potential benefit: If successful, this intervention could lead to improved developmental outcomes and reduced symptoms of ASD in infants.

How similar studies have gone: Previous studies have indicated that early interventions for ASD can lead to better outcomes, suggesting that this approach may be promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* risk-range score at SACS-R;
* Italian as one of the languages spoken at home;
* age below 18 months (corrected) at the time of identification;
* available device with webcam and home internet access.

Exclusion criteria:

* presence of a known genetic disorder, brain damage or other relevant neurological or chronic disorders;
* severe visual, auditory and/or motor impairment.

Where it's running

  • IRCCS Stella Maris
    Pisa, Italy, Italy
    Recruiting
  • Cnr
    Messina, Italy
    Recruiting
  • University of Messina
    Messina, Italy
    Recruiting
  • Istituto Italiano Tecnologia
    Rovereto, Italy, Italy
    Active not recruiting

Study contacts

  • Principal investigator: Andrea Guzzetta, MD — University of Pisa/IRCCS Stella Maris
  • Study coordinator: Andrea Guzzetta, MD
  • Email: andrea.guzzetta@fsm.unipi.it

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.